Zimmer Biomet Holdings, Inc.
ZBH
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma prodā¦ read more
Healthcare
Medical Devices
24 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$83.37
Price+4.76%
$3.79
1Y
Price
Market Cap
$16.129b
Large
Price/Earnings 3y Avg5y Avg
21.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+25.8%
EBITDA Margin+11.4%
Net Profit Margin+15.5%
Free Cash Flow Margin+25.8%
EBITDA Margin+11.4%
Net Profit Margin+15.5%
Free Cash Flow MarginRevenue
$8.409b
+2.2%
1y CAGR+4.4%
3y CAGR+4.9%
5y CAGREarnings
$761.300m
+8.0%
1y CAGR-8.6%
3y CAGR+79.2%
5y CAGREPS
$3.85
+8.5%
1y CAGR-6.9%
3y CAGR+80.8%
5y CAGRBook Value
$14.738b
$22.722b
Assets$7.984b
Liabilities$7.471b
DebtDebt to Assets
32.9%
3.4x
Debt to EBITDAFree Cash Flow
$1.836b
+24.7%
1y CAGR+16.6%
3y CAGR+15.3%
5y CAGRNo items found.
Press Releases
Statements and updates from the company